Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
MDxHealth SA (MDXH)
Company Research
Source: GlobeNewswire
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 millionAdjusted EBITDA profitability of $1.0 million for Q3Acquisition of ExoDx business from Bio-Techne CorporationConference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, CA – November 12, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced its financial results for the three and nine-month period ended September 30, 2025. Michael K. McGarrity, CEO of mdxhealth, commented: “We are pleased to report another strong quarter of growth and operating execution for mdxhealth with 18% revenue growth for the quarter and 20% growth year-to-date, coupled with continued discipline on our operating expenses which were essentially flat on a quarterly and year-to-date basis despite extraordinary ExoDx transaction expenses. Furthermore, total use of cash in Q3 was less
Show less
Read more
Impact Snapshot
Event Time:
MDXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXH alerts
High impacting MDxHealth SA news events
Weekly update
A roundup of the hottest topics
MDXH
News
- Institutions profited after MDxHealth SA's (NASDAQ:MDXH) market cap rose US$17m last week but retail investors profited the most [Yahoo! Finance]Yahoo! Finance
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at TD Cowen from $5.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at Lake Street Capital from $7.00 to $9.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth (NASDAQ:MDXH) had its price target raised by analysts at BTIG Research from $6.00 to $7.00. They now have a "buy" rating on the stock.MarketBeat
- MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
MDXH
Earnings
- 11/12/25 - Miss
MDXH
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 6-K
- 9/16/25 - Form 6-K
- MDXH's page on the SEC website